Pacira Biosciences leads in non-opioid pain relief with Exparel & upcoming knee osteoarthritis therapy. Click here to read my ...

4Moving Biotech (4MB), a spin-off of 4P-Pharma developing the first potential disease-modifying drug (DMOAD) for knee osteoarthritis, announces that it has been awarded €7.6 million in funding under ...

Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...

Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, has successfully passed the GMP on-site inspection by South Korea's ...

Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a ...

China: A recent study revealed that photodynamic therapy (PDT) demonstrated a higher overall effectiveness (91.30% vs. 75.56% ...

It is a degenerative disease that appears to be caused by both biomechanical and bio-chemical factors. Intra-articular (IA) injection treatment is one of the main treatment methods for OA because of ...

A horse’s joints are key to their ability to be mobile and agile. When horse joints are healthy, they provide a seamless ...